NCT06812416已完成不适用
Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels: A Randomized Double-Blind Parallel Trial
Qualia Life Sciences2 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2023年10月24日最近更新:
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 92
- 试验地点
- 2
- 主要终点
- Intracellular NAD+ Levels
研究概览
简要总结
The current study is designed as a randomized double-blind placebo-controlled parallel trial. It aims to investigate the efficacy of Qualia NAD+ on intracellular NAD levels in blood samples (primary outcomes) and health-related quality of life (secondary outcomes) in an adult population experiencing moderate to severe joint pain between ages of 40 and 65 years.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 40 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Provide voluntary, written, informed consent to participate in the study Agree to provide a valid cell phone number and are willing to receive communications through text.
- •Healthy male and female participants between the ages of 40-65 years of age. Willingness to complete questionnaires, records, and diaries associated with the study.
- •Willing to not consume any supplements, energy drinks/shots, or other products containing any form of supplemental vitamin B3 (e.g., niacin, niacinamide, nicotinamide ribosome, NMN) starting about 2 weeks prior to the baseline NAD fingerstick test and continuing through the intervention period.
- •Willing to not begin taking any new supplements during the study period, and to continue taking any supplements they are currently using regularly (with the exception of vitamin B3 containing supplements).
- •Willing to self-administer the intracellular NAD fingerstick test kit at home for both a baseline and post-intervention blood sample, and to complete a release form that gives NHC access to the results of these tests.
排除标准
- •Women who are pregnant, breastfeeding, or planning to become pregnant during the trial Known food intolerances/allergy to any ingredients in the product Having any of the following conditions: Psychiatric conditions, neurologic disorders, endocrine disorders, cancer Having had a significant cardiovascular event in the past 6 months Taking MAO inhibitors, SSRIs, or any other psychiatric or neurological medicines On immunosuppressive therapy Individuals who were deemed incompatible with the test protocol Adults lacking capacity to consent
研究组 & 干预措施
Qualia NAD+
Active Comparator
Qualia NAD+
干预措施: Qualia NAD+ (Dietary Supplement)
Placebo
Placebo Comparator
Rice Flour Placebo
干预措施: Rice Flour Placebo (Dietary Supplement)
结局指标
主要结局
Intracellular NAD+ Levels
时间窗: Baseline and day 28
次要结局
- Aging Male/Female Symptom scale(Baseline, day 14, and day 28)
- RAND SF-36(Baseline, day 14, and day 28)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD LevelsNAD+ Levels in the BloodNCT06505967Qualia Life Sciences200
已完成
不适用
The effects of NAD+-precursor supplementation on energy metabolism in physically compromised elderly.veroudering, energiemetabolisme.AgeingNL-OMON47902niversiteit Maastricht36
已完成
不适用
Vitamin D efficacy on COPDChronic Obstructive Pulmonary Disease (COPD).Other chronic obstructive pulmonary diseaseIRCT2017021030705N1orth Khorasan University of Medical Sciences84
尚未招募
不适用
Investigating the efficacy of supplementation with a proprietary dairy powder in supporting muscle recovery following exercise-induced muscle damage in healthy individualsMuscle damageMusculoskeletal - Normal musculoskeletal and cartilage development and functionACTRN12623000303640Dr Jocelyn Eason40
已完成
不适用
The effect of nutritional supplementation with a disease specific tube feed on the postprandial plasma glucose response in type 2 diabetic patients at baseline and after 6 and 12 weeks of supplementatioISRCTN57864852umico Research B.V. (The Netherlands)58